9.1 C
New York
Saturday, April 20, 2024
HomeMarkets
Markets

20 Stocks Moving In Thursday’s Pre-Market Session

By Insider Scoop
0
35
psw-placeholder
psw-placeholder

Courtesy of Benzinga.

Gainers

  • Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) gained 88.2 percent to $11.65 after the company reported top line results in ZYN002 open label Phase 2 FAB-C study in children with Fragile X syndrome. The study successfully met the primary endpoint.
  • Exa Corp (NASDAQ: EXA) rose 42.4 percent to $24.15 in pre-market trading. Dassault Systèmes announced plans to acquire Exa for $24.25 per share in cash.
  • Sky Solar Holdings Ltd (ADR) (NASDAQ: SKYS) shares rose 38 percent to $2.25 in the pre-market trading session. Sky Solar posted net income of $5.2 million in the first half of 2017, versus a net loss of $2.2 million in the year-ago period.
  • Aqua Metals Inc (NASDAQ: AQMS) rose 32.2 percent to $8.00 in pre-market trading after gaining 3.95 percent on Wednesday.
  • Chiasma Inc (NASDAQ: CHMA) shares rose 10.2 percent to $2.70 in pre-market trading. Chiasma reported that initial patient is randomized in Phase 3 CHIASMA OPTIMAL clinical trial.
  • Izea Inc (NASDAQ: IZEA) rose 8.3 percent to $6.40 in pre-market trading after falling 10.73 percent on Wednesday.
  • BlackBerry Ltd (NASDAQ: BBRY) shares rose 7.3 percent to $9.90 in pre-market trading after the company reported stronger-than-expected earnings for its second quarter and reported signing of first BlackBerry secure licensing deal.
  • Editas Medicine Inc (NASDAQ: EDIT) rose 5.7 percent to $21.06 in pre-market trading after declining 1.82 percent on Wednesday.
  • RedHill Biopharma Ltd – ADR (NASDAQ: RDHL) rose 5.1 percent to $9.55 in pre-market trading after dropping 3.91 percent on Wednesday.
  • Dr.Reddy’s Laboratories Ltd (ADR) (NYSE: RDY) rose 4.5 percent to $36.06 in pre-market trading after dropping 3.31 percent on Wednesday.
  • Abbott Laboratories (NYSE: ABT) rose 4.2 percent to $54.30 in pre-market trading after the company disclosed that the FDA has approved Abbott Freestyle Libre Flash Glucose Monitoring System.
  • Rex Energy Corporation (NASDAQ: REXX) rose 3.6 percent to $2.85 in pre-market trading after surging 17.02 percent on Wednesday.

Find out what’s going on in today’s market and bring any questions you have to Benzinga’s PreMarket Prep.

Losers

  • DexCom, Inc. (NASDAQ: DXCM) fell 26.6 percent to $49.55 in pre-market trading following the FDA approval of Abbott’s Blood Glucose Monitoring Device and analyst downgrades.
  • Pier 1 Imports Inc (NYSE: PIR) shares fell 9.6 percent to $4.06 in pre-market trading. Pier 1 Imports posted a narrower-than-expected loss for its second quarter. The company’s comparable sales rose 1.8 percent during the quarter.
  • ITUS Corp (NASDAQ: ITUS) shares fell 6.7 percent to $4.06 in pre-market trading after dropping 12.83 percent on Wednesday.
  • Veritone Inc (NASDAQ: VERI) shares fell 6.4 percent to $43.00 after dipping 30.28 percent on Wednesday.
  • Helios and Matheson Analytics Inc (NASDAQ: HMNY) fell 6.1 percent to $8.20 in pre-market trading after declining 5.25 percent on Wednesday.
  • Meritor Inc (NYSE: MTOR) fell 5.7 percent to $25.10 in pre-market trading after rising 1.03 percent on Wednesday.
  • 22nd Century Group Inc (NYSE: XXII) shares fell 4.1 percent to $2.60 in pre-market trading after slipping 1.09 percent on Wednesday.
  • Rite Aid Corporation (NYSE: RAD) fell 3.1 percent to $2.21 in pre-market trading after the company posted downbeat quarterly sales and named Kermit Crawford as President and COO.

Posted-In: #PreMarket Gainers LosersNews Movers & Shakers Pre-Market Outlook Markets Movers

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,349FansLike
396,312FollowersFollow
2,290SubscribersSubscribe

Latest Articles

Load more

Note: The material presented in this commentary is provided for informational purposes only and is based upon information that is considered to be reliable. However, neither PSW Investments, LLC d/b/a PhilStockWorld (PSW) nor its affiliates warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.

This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

Contact us: support@philstockworld.com

© Copyright - PSW, LLC.

2024
0
Would love your thoughts, please comment.x
()
x